CSIMarket
 
Jazz Pharmaceuticals Plc  (NASDAQ: JAZZ)
 

Jazz Pharmaceuticals Plc's Customers Performance

JAZZ



 
JAZZ's Source of Revenues During the corresponding time, Jazz Pharmaceuticals Plc recorded a revenue increase by 15.55 % year on year, sequentially revenue grew by 13.04 %. While revenue at the Jazz Pharmaceuticals Plc's corporate clients

List of JAZZ Customers




for the same period Jazz Pharmaceuticals Plc recorded revenue increase by 15.55 % year on year, sequentially revenue grew by 13.04 %.

List of JAZZ Customers

Jazz Pharmaceuticals Plc's Business Units
Product and Services, Product Sales Net of Deductions    180.53 % of total Revenue
Product and Services, Royalties and Contract Revenue    7.93 % of total Revenue
Xywav    72.78 % of total Revenue
Xyrem    5.11 % of total Revenue
Sleep    77.89 % of total Revenue
Epidiolex/Epidyolex    44.85 % of total Revenue
Epilepsy    44.85 % of total Revenue
Zepzelca    17.11 % of total Revenue
Rylaze/Enrylaze    16.82 % of total Revenue
Defitelio/defibrotide    9.05 % of total Revenue
Modeyso    7.42 % of total Revenue
Vyxeos    4.8 % of total Revenue
Ziihera    2.38 % of total Revenue
Oncology    57.58 % of total Revenue
Other    0.22 % of total Revenue
High Sodium AG Oxybate Product Royalty Revenue    6.5 % of total Revenue
All other    1.43 % of total Revenue
United States    168.64 % of total Revenue
Europe    15.71 % of total Revenue
Other Countries    4.11 % of total Revenue






Jazz Pharmaceuticals Plc's Comment on Sales, Marketing and Customers



The company provides customer experience platforms and digital learning platforms focused on leadership, personal effectiveness, and well-being. It offers self-service learning resources covering teamwork, decision-making, hybrid working, and digital skills. Tuition reimbursement is available in major markets. The company prioritizes leadership development, competitive compensation, and benefits to attract and retain talent. Well-being programs include support for mental and emotional health, physical health promotion, paid leave policies, volunteer days, and well-being reimbursement accounts. Additionally, the company supports a workplace culture with tools for remote work and collaboration.





Jazz Pharmaceuticals Plc’s Comment on Sales, Marketing and Customers


The company provides customer experience platforms and digital learning platforms focused on leadership, personal effectiveness, and well-being. It offers self-service learning resources covering teamwork, decision-making, hybrid working, and digital skills. Tuition reimbursement is available in major markets. The company prioritizes leadership development, competitive compensation, and benefits to attract and retain talent. Well-being programs include support for mental and emotional health, physical health promotion, paid leave policies, volunteer days, and well-being reimbursement accounts. Additionally, the company supports a workplace culture with tools for remote work and collaboration.








JAZZ's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Jazz Pharmaceuticals Plc 16,923.88 4,438.65 29.49 2,890
SUBTOTAL 0.00 0.00 0.00 -

Sources: Jazz Pharmaceuticals Plc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Jazz Pharmaceuticals Plc’s corporate clients.
For your research, we’ve provided 9 tables on Jazz Pharmaceuticals Plc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.